Ray Dalio acquired 50.5 Thousand Sarepta Therapeutics shares worth $4.26 Million. That's 0.02% of their equity portfolio (380th largest holding). The first Sarepta Therapeutics trade was made in Q1 2021. Since then Ray Dalio bought shares four more times and sold shares on five occasions. The stake costed the investor $3.99 Million, netting the investor a gain of 6.7% so far.